Multi-component bifurcated stent-graft systems

A multiple-component expandable endoluminal system for treating a lesion at a bifurcation including a self expandable tubular root member having a side-looking engagement aperture, a self expandable tubular trunk member comprising a substantially blood impervious polymeric liner secured therealong; both having a radially compressed state adapted for percutaneous intraluminal delivery and a radially expanded state adapted for endoluminal support.

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is continuation of U.S. application Ser. No. 12/529,936, filed Sep. 4, 2009, now U.S. Pat. No. 8,317,856, which is the US National Stage of International Patent Application PCT / IL2008 / 000287, filed Mar. 5, 2008, which published as WO 08/107885, and which claims the benefit of U.S. Provisional Applications 60/892,885, filed Mar. 5, 2007, and 60/991,726, filed Dec. 2, 2007.

FIELD OF THE INVENTION

The present invention relates generally to endoluminal grafts, and particularly to bifurcated endoluminal grafts.

BACKGROUND OF THE INVENTION

For a few decades, conventional treatment of abdominal aortic aneurysms (AAA) was limited either to a sit-and-wait strategy, or in cases with too high a risk for aneurysm rupture, a surgical operation using vascular grafts introduced in major open abdominal surgery.

While long term clinical results of the surgical approach were favorable and the treated patients did not need frequent follow-ups, nevertheless the short-term morbidity, including complication rate, hospitalization time, out-of-work period and related expenses warranted continued search for a less invasive, but still definitive, solution of the problem.

Numerous attempts have been made to introduce such definitive treatments to AAA that involve less morbidity, a shorter hospitalization period and lower related costs, and enable the patient to return to routine life sooner. These initiatives resulted in various endovascular stent-grafts that are commercially available or are being clinically and pre-clinically evaluated. A major advantage in these newer devices is that their implantation involves a significantly less invasive procedure, including creating an endovascular working channel—usually via an incision in the groin area—to the diseased abdominal aorta, through which a self expandable stent-graft is typically introduced. In most cases, a bifurcated device is employed, either in one piece, or in some cases, smaller caliber iliac-grafts are deployed subsequently after the main aortic devices have been well positioned.

Nonetheless, the relatively new endovascular approach has its share of problems and limitations. Some of the major outstanding problems include:

    • The implantation is complicated because most AAA stent grafts are implanted via two working channels, one in each side of the groin. The interventional radiologist typically has to introduce one main piece of the device via one working channel and an extension piece through the other side in a non trivial manner.
    • There is a prolonged implantation procedure caused by a difficulty to correctly position the stent-graft and the inability to correct its position once deployed, usually due to barbs that penetrate the aortic wall and anchor the graft thereto. This also involves relatively high doses of X-ray radiation, to which the patient and the staff are exposed during the prolonged endovascular procedure.
    • In earlier AAA stent grafts, device migration was a major issue, sometimes leading to obstruction of blood flow into the neighboring renal arteries or in other cases exposing the aneurysm to renewed blood penetration. Conventional AAA stent-grafts were typically prone to migration since they are essentially built along a single longitudinal axis and they may migrate along the same axis.
    • Endovascular leaks (in short—endoleaks) are another problem. Two types of endoleaks are defined: A type I endoleak is leakage of blood around the stent-graft and into the aneurismal sac, which may lead to rupturing the aneurysm. A Type II endoleak occurs when blood/plasma leaks through the graft wall and into the aneurismal space. Type II endoleaks have been mostly resolved by the introduction of finer-woven graft fabrics, performing pre-clotting procedures and/or incorporation of collagen or other procoagulation materials into the graft wall. Type I endoleaks are nonetheless more difficult to prevent and treat.
    • The device cost is very high. Current self-expandable AAA stent-grafts are usually bifurcated grafts, one piece or multi-piece devices. The connection with the graft fabric is typically achieved by hand stitching to a metallic, self-expandable frame. Hand labor related issues together with the critical QA/QC standards with which these devices have to comply make these devices quite expensive to manufacture.
    • There are the necessary follow-ups which are time consuming.

SUMMARY OF THE INVENTION

The present invention seeks to provide novel bifurcated endoluminal grafts that overcome the abovementioned problems of the prior art, as described more in detail hereinbelow. The present invention seeks to reduce the laborious and complicated multi-step medical procedures and related cost of the device. The present invention involves significantly fewer, simpler, quicker and more definitive medical steps. The present invention uses simpler device modules, which make the endovascular treatment of AAA quicker, safer for the patient and the treating staff, more reliable and cheaper.

The present invention can reduce the number of vascular access sites from two femoral arteries in both sides of the groin to a single vascular access site. The present invention can reduce the risk of device migration in AAA stent grafts.

There is provided in accordance with an embodiment of the invention a stent graft system including a first component 60 including a tubular structure having a support element 63 and a covering element 62 attached thereto, the first component 60 being positionable in first and second branches that bridge a main trunk of a subject and wherein the first and second elements have an opening 61 arranged to face the main trunk, and a second component 70 having a generally cylindrical form with a support element 72 and a covering element 71 attached thereto, the second component 70 configured to be at least partially disposed within the first component 60, outwardly extending from the opening 61 in the first component 60.

One or both of the first and second components may be adapted for transluminal delivery for transport to a site within a body lumen by being radially compressed from a larger cross-section to a smaller cross-section.

In accordance with an embodiment of the invention the covering element of the first component only partially covers the support element of the first component.

In accordance with an embodiment of the invention the covering element of the second component only partially covers the support element of the second component.

Further in accordance with an embodiment of the invention the first and second components are radially compressible from a larger cross-section to a smaller cross-section, and wherein the first and second components are adapted for transluminal delivery for transport to a site within a body lumen, and wherein the second component is adapted for transluminal delivery through the first component in its larger cross-section and to outwardly extend from the opening in the first component. For example, the first component in its larger cross-section may be dimensioned to intraluminally fit iliac arteries of a subject and the second component in its larger cross-section may be dimensioned to intraluminally fit an abdominal aorta of the subject.

In accordance with an embodiment of the invention the second component includes a proximal segment and a distal segment, and wherein the covering element substantially spans the distal segment but does not generally span the proximal segment. The proximal segment may be dimensioned to be anchorably disposed within the first component. The proximal segment of the second component may be substantially disposed within the first component. The distal segment of the second component may outwardly extend from the opening in the first component.

There is provided in accordance with an embodiment of the invention a method including implanting a stent graft system into a bifurcation in a body lumen, the bifurcation including a main trunk and first and second branches, wherein a first component of the system is disposed within the first and second branches bridging the main trunk and wherein the first and second elements have an opening aligned to face the main trunk, and implanting a second component in the main trunk such that at least a portion of the second component is located within the main trunk and at least a portion of the second component is located within the first component.

There is provided in accordance with an embodiment of the invention a multiple-component expandable endoluminal system for treating a lesion at a bifurcation including a self expandable tubular root member having a side-looking engagement aperture, a self expandable tubular trunk member including a substantially blood impervious polymeric liner secured therealong, both having a radially compressed state adapted for percutaneous intraluminal delivery and a radially expanded state adapted for endoluminal support, wherein root member and the trunk member are individually deployable, and wherein the trunk member is substantially non compressible along its longitudinal axis, and wherein the circumference of the side-looking engagement aperture is capable of having a substantially identical shape as the circumference of the body portion of the trunk member in its radially relaxed state, and wherein the trunk member is adapted to be inserted intraluminally through either ends of root member when in its deployable state and thereafter extraluminally substantially exiting through its side-looking engagement aperture and perpendicular thereto, and wherein the distal end of trunk member is adapted to be anchorably deployable through the side-looking engagement aperture.

BRIEF DESCRIPTION OF THE DRAWINGS

The present invention will be understood and appreciated more fully from the following detailed description, taken in conjunction with the drawings in which:

FIG. 1 is a simplified pictorial illustration of one possible insertion step in the deployment of an endoluminal graft in a non-limiting embodiment of the present invention;

FIG. 2 is a simplified pictorial illustration of another deployment step of the endoluminal graft in a non-limiting embodiment of the present invention;

FIG. 3 is a simplified pictorial illustration of a stent graft component of the endoluminal graft free of its catheter and positioned such that it has an open end located within each bifurcation branch and an aperture is facing the main trunk;

FIG. 4 is a simplified pictorial illustration of another deployment step of the endoluminal graft in a non-limiting embodiment of the present invention;

FIG. 5 is a simplified pictorial illustration of another deployment step of the endoluminal graft in a non-limiting embodiment of the present invention;

FIG. 6 is a simplified pictorial illustration of the stent graft system in place in accordance with an embodiment of the present invention;

FIGS. 7-12 are simplified pictorial illustrations of another preferred embodiment of the present invention, wherein a catheter is inserted in a fashion similar to the embodiments of FIGS. 4-6;

FIG. 13 is a simplified pictorial illustration of a non-limiting embodiment of an anchoring mechanism between first and second stent graft components;

FIG. 14 is a simplified pictorial illustration of another non-limiting embodiment of an anchoring mechanism between stent graft components;

FIG. 15A is a simplified pictorial illustration of a non-limiting embodiment of a stent graft component with an aperture evident in the graft material;

FIGS. 15B and 15C are simplified pictorial illustrations of a non-limiting embodiment of stent graft component wherein the component includes sections with varying diameters; and

FIGS. 16A and 16B are simplified pictorial illustrations of the flow of blood through the joined stent graft components.

 DESCRIPTION OF EMBODIMENTS

Reference is now made to FIG. 1, which illustrates one possible insertion step in the deployment of a component of an endoluminal graft in a non-limiting embodiment of the present invention. A catheter 100 is percutaneously inserted into a bifurcation 12 (e.g., one iliac artery) extending from a main trunk 10, using conventional transluminal methods, such as with a guidewire 50. The catheter 100 is bent or deflected at an angle so that it passes the main lumen and is then introduced into a second bifurcation 13 (e.g., the second iliac artery) extending from the main trunk 10. FIG. 1 shows two branch arteries (arterial ostia) 14 and 15 branching from main trunk 10. There is an aneurysm 11 in the main trunk 10. Catheter 100 includes two catheter portions 101 and 102. Bifurcations 12 and 13 may also be referred to as arterial ostia 12 and 13.

Reference is now made to FIG. 2, which illustrates another deployment step of a component in a non-limiting embodiment of the present invention. Both the distal and proximal ends of the catheter portions 101 and 102, respectively, are moved in opposite directions (e.g., by suitable manipulation of guide wires attached thereto, not shown) so that a stent graft component 60 which is in a compressed state within the catheter is gradually freed. An aperture 61 in the stent graft component 60 is positioned by the operator (e.g., by suitable manipulation of a guide wire attached thereto, not shown, and assisted by imaging such as fluoroscopy) such that it faces the main trunk 10. FIG. 3 illustrates the stent graft component 60 free of its catheter and positioned such that it has an open end located within each bifurcation 12 and 13 respectively, while aperture 61 is facing the main trunk 10.

Reference is now made to FIG. 4, which illustrates another deployment step of a component in a non-limiting embodiment of the present invention. A second catheter 200 is inserted through one open end of the first stent graft component 60 so that its distal end extend through the aperture 61 in the first stent graft component and is located within the main trunk 10.

Reference is now made to FIG. 5, which illustrates another deployment step of a component in a non-limiting embodiment of the present invention. A second stent graft component 70 is gradually freed from its restraining catheter. Catheter outer tube 202 is withdrawn so that the stent graft component 70 is gradually free to expand in a radial direction, such that the graft component's distal end engages the walls of the main trunk 10 below arterial ostia 12 and 13, for example, the renal artery ostia. As the second stent graft component 70 is freed from the circumferential confines of the outer catheter tube 202, its proximal end engages the first stent graft component 60, thus anchoring the second stent graft component 70 to the first stent graft component 60.

FIG. 6 schematically illustrates the stent graft system in place, with the second stent graft component 70 having one end engaged radially against the wall of the main trunk 10 under arterial ostia 12 and 13, while its proximal end is concentrically located within one end of the first stent graft component 60.

FIGS. 7 through 12 illustrate another preferred embodiment of the present invention, wherein a catheter 70 is inserted in a fashion similar to the one described in FIGS. 4, 5 and 6. Stent graft component 70 is freed from its catheter 200 by retracting outer catheter tube 202 so that its distal end is free within the main trunk lumen. The distal end of said second stent graft component 70 may or may not touch the lumen walls of the main trunk. The proximal end of the second stent is located concentrically within one section of the first stent graft component 60 so that it is anchored by the first stent graft component. A catheter 300 is inserted in a similar fashion through an open end of the first stent graft component 60, and through the proximal end of the second stent graft component 70 located concentrically within the first stent graft component 60. Catheter 300 is inserted such that its proximal end extends beyond the open distal end of the second stent graft component 70. A third stent graft component 80 is released from the catheter so that its distal end radially engages the lumen walls of the main trunk 10. As the third stent graft component 80 is further released, its proximal end engages the second stent graft component 70 in a radial fashion, forming an anchoring point between the second stent graft component 70 and the third stent graft component 80.

FIG. 12 shows elements of stent graft component 80 engaging the lumen walls of main trunk 10 such that support elements 82 engage the lumen wall above arterial ostia 12 and 13. Graft covering 81 does not extend above the arterial ostia so as not to block blood flow into the ostia 14 and 15.

FIG. 13 schematically illustrates a non-limiting embodiment of the anchoring mechanism between the first stent graft component 60 and the second stent graft component 70. In this embodiment, engagement arms 73 and 74 are located circumferentially on the second stent graft component 70 in at least two rows above and below aperture 61 in stent graft component 60. The rows of engagement arms 73 and 74 are formed so as to grasp both sides of aperture 61 in stent graft component 60. The two stent graft components are joined together as a result.

FIG. 14 schematically illustrates another non-limiting embodiment of the anchoring mechanism between stent graft component 60 and stent graft component 70 whereby the proximal end of stent graft component 70 is concentrically located within at least a portion of stent graft component 60 with a section of the second stent graft component 70 extending through the aperture 61 and within a portion of stent graft component 60. The graft covering 71 does not necessarily extend throughout the length of stent graft component 70.

FIG. 15A schematically illustrates a non-limiting embodiment of stent graft component 60 wherein aperture 61 is evident in the graft material covering component 61. The graft covering 62 may be connected to support section 63 by means of sutures, adhesives or any suitable means. Aperture 61 in the graft covering 62 may be equal in size to the aperture affected in support structure 63. Flaring may be introduced to component ends 65 in order to better engage a body lumen (not shown) when implanted.

FIGS. 15B and 15C schematically illustrates a non-limiting embodiment of stent graft component 70 wherein component 70 may have include sections with varying diameters, so that a portion of component 70 may be deposited within a section of component 60 (not shown). FIG. 15C shows another embodiment wherein circumferential engagement arms 74 may be formed so as to engage portions of component 60 (not shown) so as to anchor both components together.

FIGS. 16A and 16B show the flow of blood through the joined stent graft components 60 and 70. It is important to allow blood flow to both sides of component 60 so as not to cause ischemia. FIG. 16B illustrates that component 70 is not covered throughout by a graft covering so as to allow blood flow to both sides.

The scope of the present invention includes both combinations and subcombinations of the features described hereinabove as well as modifications and variations thereof which would occur to a person of skill in the art upon reading the foregoing description and which are not in the prior art.

Claims

1. A stent graft system comprising:

a first component, which comprises a tubular structure, which comprises a first support element and a first covering element attached to said first support element, two sides of said first component being positionable, respectively, in first and second branching arteries that branch from a main artery of a subject, wherein said first covering element is shaped so as to define an opening arranged to face said main artery; and
a second component, which comprises a second support element and a second covering element attached to said second support element,
wherein said second component comprises a proximal segment and a distal segment, said proximal segment anchorably disposed within said first component, such that said distal segment of said second component extends out of said first component through said opening,
wherein a diameter of a distal section of said distal segment not disposed within said first component is greater than a diameter of said opening, and
wherein said diameter of said distal section increases as said distal section exits from said opening.

2. The stent graft system according to claim 1, wherein said first component is adapted for transluminal delivery for transport to a site within a body lumen by being radially compressed from a larger cross-section to a smaller cross-section.

3. The stent graft system according to claim 1, wherein said second component is adapted for transluminal delivery for transport to a site within a body lumen by being radially compressed from a larger cross-section to a smaller cross-section.

4. The stent graft system according to claim 1, wherein said first covering element only partially covers said first support element.

5. The stent graft system according to claim 1, wherein said first and second components are radially compressible from respective larger cross-sections to respective smaller cross-sections, wherein said first and second components are adapted for transluminal delivery for transport to a site within a body lumen, and wherein said second component is adapted for transluminal delivery through said first component when said first component assumes its larger cross-section.

6. The stent graft system according to claim 5, wherein said first component, when it assumes its larger cross-section, is dimensioned to intraluminally fit iliac arteries of said subject, and wherein said second component, when it assumes its larger cross-section, is dimensioned to intraluminally fit an abdominal aorta of said subject.

7. The stent graft system according to claim 1, wherein said proximal segment is dimensioned to be anchorably disposed within exactly one of said two sides of said first component, such that said proximal segment engages said exactly one side.

8. The stent graft system according to claim 7, wherein said proximal segment of said second component is concentrically located within said exactly one of said two sides of said first component when said proximal segment is anchorably disposed within said first component.

9. The stent graft system according to claim 1, wherein a section of said second covering element extends through said opening and within a portion of said first component when said proximal segment is anchorably disposed within said first component.

10. The stent graft system according to claim 1, wherein said first component widens in a vicinity of said opening.

11. The stent graft system according to claim 1, wherein said first component is configured such that a perimeter of said opening is less than a perimeter of supports of said first component surrounding said opening, such that a portion of said first covering element surrounding said opening extends from said supports towards said opening.

12. The stent graft system according to claim 1, wherein said second component has a generally cylindrical form.

13. A method comprising:

implanting, respectively in first and second iliac arteries that branch from an abdominal aorta of a subject, two sides of a first component of a stent graft system, which first component includes a tubular structure that includes a first support element and a first covering element attached to said first support element, such that an opening defined by said first covering is aligned to face said abdominal aorta; and
thereafter, implanting a second component of said system, which second component includes a second support element and a second covering attached to said second support element, by: transluminally advancing a catheter tube through one open end of exactly one of said two sides of said first component and out through the opening into the abdominal aorta, while said second component is radially compressed within said catheter tube, and withdrawing said catheter tube so that (a) at least a distal segment of said second component is freed from said catheter tube, extends out of said first component through said opening, and radially expands within said abdominal aorta, and (b) thereafter, at least a proximal segment of said second component is freed from said catheter tube and radially expands within said first component, thereby anchoring said at least a proximal segment of said second component to said first component, such that a distal section of said distal segment that is not disposed within said first component and radially expands within said abdominal aorta has a diameter that (a) is greater than a diameter of said opening, and (b) increases as said distal segment exits from said opening.

14. The method according to claim 13, wherein withdrawing said catheter tube comprises withdrawing said catheter tube such that the at least a proximal segment of said second component is freed from said catheter tube and radially expands within said exactly one of said two sides of said first component.

15. The method according to claim 14, wherein anchoring said at least a proximal segment of said second component comprises concentrically locating said at least a proximal segment of said second component within said exactly one of said two sides of said first component.

16. The method according to claim 13, wherein anchoring said at least a proximal portion of said second component comprises disposing said second component such that a section of said second covering element extends through said opening and within a portion of said first component.

17. The method according to claim 13,

wherein said catheter tube is a second catheter tube, and
wherein implanting said first component comprises transluminally delivering said first component by: advancing a first catheter tube into said first and second iliac arteries, while said first component is radially compressed within said first catheter tube, and thereafter freeing said first component from said first catheter tube such that said first component radially expands in said first and second iliac arteries.

18. The method according to claim 13, wherein said second component is generally cylindrical.

Referenced Cited
U.S. Patent Documents
4355426 October 26, 1982 MacGregor
4505767 March 19, 1985 Quin
4562596 January 7, 1986 Komberg
4577631 March 25, 1986 Kreamer
4617932 October 21, 1986 Komberg
4665906 May 19, 1987 Jervis
4739762 April 26, 1988 Palmaz
4787899 November 29, 1988 Lazarus
4878906 November 7, 1989 Lindemann et al.
4886062 December 12, 1989 Wiktor
4938740 July 3, 1990 Melbin
4969458 November 13, 1990 Wiktor
5042707 August 27, 1991 Taheri
5064435 November 12, 1991 Porter
5122136 June 16, 1992 Guglielmi et al.
5133732 July 28, 1992 Wiktor
5234448 August 10, 1993 Wholey et al.
5486183 January 23, 1996 Middleman et al.
5507769 April 16, 1996 Marin et al.
5509923 April 23, 1996 Middleman et al.
5522880 June 4, 1996 Barone et al.
5527322 June 18, 1996 Klein et al.
5554181 September 10, 1996 Das
5562724 October 8, 1996 Vorwerk et al.
5613974 March 25, 1997 Andreas et al.
5632746 May 27, 1997 Middleman et al.
5632763 May 27, 1997 Glastra
5632772 May 27, 1997 Alcime et al.
5639278 June 17, 1997 Dereume et al.
5643340 July 1, 1997 Nunokawa
5653743 August 5, 1997 Martin
5676696 October 14, 1997 Marcade
5676697 October 14, 1997 McDonald
5693084 December 2, 1997 Chuter
5728134 March 17, 1998 Barak
5749879 May 12, 1998 Middleman et al.
5755770 May 26, 1998 Ravenscroft
5755771 May 26, 1998 Penn et al.
5755777 May 26, 1998 Chuter
5769882 June 23, 1998 Fogarty et al.
5769884 June 23, 1998 Solovay
5782903 July 21, 1998 Wiktor
5782906 July 21, 1998 Marshall et al.
5824040 October 20, 1998 Cox et al.
5824055 October 20, 1998 Spiridigliozzi
5860991 January 19, 1999 Klein et al.
5876432 March 2, 1999 Lau et al.
5906641 May 25, 1999 Thompson et al.
5921994 July 13, 1999 Andreas et al.
5948018 September 7, 1999 Dereume et al.
6015431 January 18, 2000 Thornton et al.
6016810 January 25, 2000 Ravenscroft
6030414 February 29, 2000 Taheri
6033435 March 7, 2000 Penn et al.
6036723 March 14, 2000 Anidjar
6059824 May 9, 2000 Taheri
6099497 August 8, 2000 Adams et al.
6117145 September 12, 2000 Wood et al.
6129738 October 10, 2000 Lashinski
6156064 December 5, 2000 Chouinard
6200339 March 13, 2001 Leschinsky et al.
6206893 March 27, 2001 Klein et al.
6270524 August 7, 2001 Kim
6283991 September 4, 2001 Cox et al.
6290720 September 18, 2001 Khosravi et al.
6325819 December 4, 2001 Pavcnik
6325823 December 4, 2001 Horzewski et al.
6344056 February 5, 2002 Dehdashtian
6395018 May 28, 2002 Castaneda
6406420 June 18, 2002 McCarthy
6428565 August 6, 2002 Wisselink
6506211 January 14, 2003 Skubitz et al.
6520988 February 18, 2003 Colombo
6576009 June 10, 2003 Ryan
6613078 September 2, 2003 Barone
6635083 October 21, 2003 Cheng et al.
6645242 November 11, 2003 Quinn
6648911 November 18, 2003 Sirhan
6652567 November 25, 2003 Deaton
6652571 November 25, 2003 White
6656214 December 2, 2003 Fogarty et al.
6692520 February 17, 2004 Gambale et al.
6695833 February 24, 2004 Frantzen
6695875 February 24, 2004 Stelter
6733523 May 11, 2004 Shaolian et al.
6743195 June 1, 2004 Zucker
6752826 June 22, 2004 Holloway et al.
6776794 August 17, 2004 Hong et al.
6814749 November 9, 2004 Cox et al.
6814752 November 9, 2004 Chuter
6824560 November 30, 2004 Pelton
6843803 January 18, 2005 Ryan
6846321 January 25, 2005 Zucker
6860900 March 1, 2005 Clerc
6907285 June 14, 2005 Denker et al.
6908477 June 21, 2005 McGuckin, Jr. et al.
6929660 August 16, 2005 Ainsworth et al.
6942691 September 13, 2005 Chuter
6964679 November 15, 2005 Marcade et al.
6986774 January 17, 2006 Middleman et al.
7008441 March 7, 2006 Zucker
7018400 March 28, 2006 Lashinski
7044962 May 16, 2006 Elliott
7105015 September 12, 2006 Goshgarian
7105020 September 12, 2006 Greenberg et al.
7112217 September 26, 2006 Kugler et al.
7115127 October 3, 2006 Lindenbaum et al.
7122052 October 17, 2006 Greenhalgh
7131991 November 7, 2006 Zarins
7144421 December 5, 2006 Carpenter et al.
7160318 January 9, 2007 Greenberg et al.
7175651 February 13, 2007 Kerr
7201772 April 10, 2007 Schwammenthal et al.
7220274 May 22, 2007 Quinn
7223266 May 29, 2007 Lindenbaum et al.
7279003 October 9, 2007 Berra et al.
7294147 November 13, 2007 Hartley
7306623 December 11, 2007 Watson
7341598 March 11, 2008 Davidson et al.
7393357 July 1, 2008 Stelter
7407509 August 5, 2008 Greenberg et al.
7413573 August 19, 2008 Hartley
7425219 September 16, 2008 Quadri
7429269 September 30, 2008 Schwammenthal et al.
7438721 October 21, 2008 Doig
7442204 October 28, 2008 Schwammenthal et al.
7473272 January 6, 2009 Pryor
7491231 February 17, 2009 Nazzaro
7537606 May 26, 2009 Hartley
7537609 May 26, 2009 Davidson et al.
7540881 June 2, 2009 Meyer et al.
7544160 June 9, 2009 Gross
7575590 August 18, 2009 Watson
7637939 December 29, 2009 Tischler
7645298 January 12, 2010 Hartley
7655036 February 2, 2010 Goodson
7662161 February 16, 2010 Briganti et al.
7662168 February 16, 2010 McGuckin, Jr. et al.
7670369 March 2, 2010 Schaeffer
7678141 March 16, 2010 Greenan et al.
7699885 April 20, 2010 Leonhardt
7708704 May 4, 2010 Mitelberg
7722626 May 25, 2010 Middleman et al.
7731732 June 8, 2010 Ken
7766955 August 3, 2010 Vardi
7771465 August 10, 2010 Zukowski
7789903 September 7, 2010 Spiridigliozzi
7806923 October 5, 2010 Moloney
7815673 October 19, 2010 Bloom et al.
7833259 November 16, 2010 Boatman
7846194 December 7, 2010 Hartley
7850725 December 14, 2010 Vardi
7867270 January 11, 2011 Hartley
7887575 February 15, 2011 Kujawski
7914572 March 29, 2011 Hartley
7955373 June 7, 2011 Sowinski
7955374 June 7, 2011 Erickson
7959662 June 14, 2011 Erbel et al.
7959669 June 14, 2011 Chalekian
7998186 August 16, 2011 Hartley
7998187 August 16, 2011 Hartley
8012193 September 6, 2011 Hartley
8021412 September 20, 2011 Hartley
8043365 October 25, 2011 Thramann
8048140 November 1, 2011 Purdy
8048147 November 1, 2011 Adams
8052736 November 8, 2011 Doig
8052741 November 8, 2011 Bruszewski
8100960 January 24, 2012 Bruszewski
8118854 February 21, 2012 Bowe
8133267 March 13, 2012 Leonhardt
8157810 April 17, 2012 Case et al.
8167926 May 1, 2012 Hartley
8172895 May 8, 2012 Anderson
8197475 June 12, 2012 Bruszewski
8197533 June 12, 2012 Kujawski
8211158 July 3, 2012 Wolf
8216298 July 10, 2012 Wright
8226706 July 24, 2012 Hartley
8236040 August 7, 2012 Mayberry
8251963 August 28, 2012 Chin et al.
8257423 September 4, 2012 Kerr
8262719 September 11, 2012 Erickson
8273115 September 25, 2012 Hamer
8287586 October 16, 2012 Schaeffer
8292885 October 23, 2012 Bruszewski
8292941 October 23, 2012 Muzslay
8292949 October 23, 2012 Berra
8292951 October 23, 2012 Muzslay
8333800 December 18, 2012 Bruszewski
8337546 December 25, 2012 Bruszewski
8353898 January 15, 2013 Lutze et al.
8357192 January 22, 2013 Mayberry
8361134 January 29, 2013 Hartley
8394136 March 12, 2013 Hartley
8425585 April 23, 2013 Melsheimer
8470018 June 25, 2013 Hartley
8475513 July 2, 2013 Sithian
8480726 July 9, 2013 Cunningham
8491646 July 23, 2013 Schreck
8506622 August 13, 2013 Bruszewski
20010014823 August 16, 2001 Resseman et al.
20010037142 November 1, 2001 Stelter et al.
20010044652 November 22, 2001 Moore
20010053930 December 20, 2001 Kugler et al.
20020052643 May 2, 2002 Wholey et al.
20020072790 June 13, 2002 McGuckin, Jr. et al.
20020099441 July 25, 2002 Dehdashtian
20020123791 September 5, 2002 Harrison
20020156495 October 24, 2002 Brenneman et al.
20020198585 December 26, 2002 Wisselink
20030033005 February 13, 2003 Houser et al.
20030093145 May 15, 2003 Lawrence-Brown et al.
20030130720 July 10, 2003 DePalma et al.
20030153968 August 14, 2003 Geis et al.
20030199967 October 23, 2003 Hartley et al.
20030212449 November 13, 2003 Cox
20030236567 December 25, 2003 Elliot
20040015227 January 22, 2004 Vardi et al.
20040106972 June 3, 2004 Deaton
20040106978 June 3, 2004 Greenberg et al.
20040117003 June 17, 2004 Ouriel et al.
20040133266 July 8, 2004 Clerc et al.
20040138735 July 15, 2004 Shaolian et al.
20040171978 September 2, 2004 Shalaby
20040181149 September 16, 2004 Langlotz et al.
20040215319 October 28, 2004 Berra et al.
20040215327 October 28, 2004 Doig et al.
20040260383 December 23, 2004 Stelter et al.
20050033406 February 10, 2005 Bamhart et al.
20050049678 March 3, 2005 Cocks et al.
20050065545 March 24, 2005 Wallace
20050102018 May 12, 2005 Carpenter et al.
20050102021 May 12, 2005 Osborne
20050131517 June 16, 2005 Hartley et al.
20050149166 July 7, 2005 Schaeffer et al.
20050159803 July 21, 2005 Lad et al.
20050165480 July 28, 2005 Jordan et al.
20050171598 August 4, 2005 Schaeffer
20050171599 August 4, 2005 White
20050177132 August 11, 2005 Lentz et al.
20050203606 September 15, 2005 VanCamp
20050216018 September 29, 2005 Sennett et al.
20050222668 October 6, 2005 Schaeffer et al.
20050222669 October 6, 2005 Purdy
20050234542 October 20, 2005 Melsheimer
20050266042 December 1, 2005 Tseng
20050273155 December 8, 2005 Bahler et al.
20060015170 January 19, 2006 Jones et al.
20060030921 February 9, 2006 Chu
20060052799 March 9, 2006 Middleman et al.
20060069426 March 30, 2006 Weinberger
20060100684 May 11, 2006 Elliott
20060116748 June 1, 2006 Kaplan et al.
20060149360 July 6, 2006 Schwammenthal et al.
20060155358 July 13, 2006 LaDuca et al.
20060155359 July 13, 2006 Watson
20060155366 July 13, 2006 LaDuca et al.
20060167476 July 27, 2006 Burdulis, Jr. et al.
20060193892 August 31, 2006 Furst et al.
20060229709 October 12, 2006 Morris et al.
20060241740 October 26, 2006 Vardi et al.
20060281966 December 14, 2006 Peacock, III
20070021822 January 25, 2007 Boatman
20070043425 February 22, 2007 Hartley et al.
20070055350 March 8, 2007 Erickson et al.
20070055358 March 8, 2007 Krolik et al.
20070055360 March 8, 2007 Hanson et al.
20070060989 March 15, 2007 Deem et al.
20070073373 March 29, 2007 Bonsignore
20070088425 April 19, 2007 Schaeffer
20070112344 May 17, 2007 Keilman
20070135677 June 14, 2007 Miller et al.
20070142896 June 21, 2007 Anderson et al.
20070150051 June 28, 2007 Arnault De La Menardiere et al.
20070156167 July 5, 2007 Connors et al.
20070167898 July 19, 2007 Peters et al.
20070179598 August 2, 2007 Duerig
20070185565 August 9, 2007 Schwammenthal et al.
20070208410 September 6, 2007 Berra et al.
20070213805 September 13, 2007 Schaeffer et al.
20070219610 September 20, 2007 Israel
20070219627 September 20, 2007 Chu
20070225797 September 27, 2007 Krivoruhko
20070233229 October 4, 2007 Berra et al.
20070237973 October 11, 2007 Purdy et al.
20070244542 October 18, 2007 Greenan et al.
20070244543 October 18, 2007 Mitchell
20070244547 October 18, 2007 Greenan
20070255388 November 1, 2007 Rudakov et al.
20080002871 January 3, 2008 Gunzert-Marx et al.
20080015673 January 17, 2008 Chuter
20080058918 March 6, 2008 Watson
20080109066 May 8, 2008 Quinn
20080114445 May 15, 2008 Melsheimer et al.
20080147173 June 19, 2008 McIff et al.
20080167704 July 10, 2008 Wright et al.
20080269789 October 30, 2008 Eli
20080275540 November 6, 2008 Wen
20080275542 November 6, 2008 LaDuca et al.
20080288044 November 20, 2008 Osborne
20080319528 December 25, 2008 Yribarren et al.
20090012597 January 8, 2009 Doig et al.
20090012602 January 8, 2009 Quadri
20090030502 January 29, 2009 Sun et al.
20090048663 February 19, 2009 Greenberg
20090069881 March 12, 2009 Chalekian et al.
20090099648 April 16, 2009 Yu
20090099649 April 16, 2009 Chobotov et al.
20090105809 April 23, 2009 Lee et al.
20090112233 April 30, 2009 Xiao
20090125096 May 14, 2009 Chu et al.
20090138067 May 28, 2009 Pinchuk et al.
20090149877 June 11, 2009 Hanson et al.
20090240316 September 24, 2009 Bruszewski
20090248134 October 1, 2009 Dierking et al.
20090254170 October 8, 2009 Hartley et al.
20090259290 October 15, 2009 Bruszewski et al.
20090287145 November 19, 2009 Cragg et al.
20100063575 March 11, 2010 Shalev
20100070019 March 18, 2010 Shalev
20100161026 June 24, 2010 Brocker et al.
20100292774 November 18, 2010 Shalev
20110093002 April 21, 2011 Rucker et al.
20110208289 August 25, 2011 Shalev
20110208296 August 25, 2011 Duffy et al.
20110208297 August 25, 2011 Tuval et al.
20110208298 August 25, 2011 Tuval et al.
20110218607 September 8, 2011 Arbefeuille et al.
20110264184 October 27, 2011 Heltai
20110288622 November 24, 2011 Chan et al.
Foreign Patent Documents
2 497 704 March 2004 CA
2497704 March 2004 CA
1 177 780 February 2002 EP
1177780 February 2002 EP
1 325 716 July 2003 EP
1325716 July 2003 EP
2002-253682 September 2002 JP
03/099108 December 2003 WO
2004/017868 March 2004 WO
2004017868 March 2004 WO
2005/002466 January 2005 WO
2005002466 January 2005 WO
2005/037138 April 2005 WO
2005/041781 May 2005 WO
2005/041783 May 2005 WO
2006/007389 January 2006 WO
2006007389 January 2006 WO
2006/028925 March 2006 WO
2006/070372 July 2006 WO
2006070372 July 2006 WO
2007/084547 July 2007 WO
2007084547 July 2007 WO
2007/144782 December 2007 WO
2008/140796 January 2008 WO
2008008291 January 2008 WO
2008/035337 March 2008 WO
2008035337 March 2008 WO
2008/042266 April 2008 WO
2008/047092 April 2008 WO
2008/047354 April 2008 WO
2008042266 April 2008 WO
2008047092 April 2008 WO
2008047354 April 2008 WO
2008/053469 May 2008 WO
2008/107885 September 2008 WO
2008140796 November 2008 WO
2009/078010 June 2009 WO
2009/116041 September 2009 WO
2009/116042 September 2009 WO
2009116041 September 2009 WO
2009116042 September 2009 WO
2009118733 October 2009 WO
2010/024869 March 2010 WO
2010/024879 March 2010 WO
2010/031060 March 2010 WO
2010024869 March 2010 WO
2010024879 March 2010 WO
2010031060 March 2010 WO
2010/045238 April 2010 WO
2010045238 April 2010 WO
2010/062355 June 2010 WO
2010062355 June 2010 WO
2010/088776 August 2010 WO
2010088776 August 2010 WO
2010128162 November 2010 WO
2010/150208 December 2010 WO
2011/004374 January 2011 WO
2011/007354 January 2011 WO
2011/055364 May 2011 WO
2011/064782 June 2011 WO
2011/067764 June 2011 WO
2011/070576 June 2011 WO
2011/080738 July 2011 WO
2011/095979 August 2011 WO
2011/106532 September 2011 WO
2011/106533 September 2011 WO
2011/106544 September 2011 WO
2011106532 September 2011 WO
2011106533 September 2011 WO
2011106544 September 2011 WO
Other references
  • An Office Action dated Mar. 24, 2011, which issued during the prosecution of U.S. Appl. No. 12/529,936.
  • An Office Action dated Oct. 28, 2011, which issued during the prosecution of U.S. Appl. No. 12/529,936.
  • An Interview Summary dated Feb. 28, 2012, which issued during the prosecution of U.S. Appl. No. 12/529,936.
  • A Notice of Allowance dated Aug. 2, 2012, which issued during the prosecution of U.S. Appl. No. 12/529,936.
  • English Abstract of Japanese Publication JP 2002-253682, published on Sep. 10, 2002.
  • An International Search Report dated Feb. 18, 2010, which issued during the prosecution of Applicant's PCT/IL08/000287.
  • A Written Opinion dated Nov. 12, 2009, which issued during the prosecution of Applicant's PCT/IL08/000287.
  • An International Search Report dated Apr. 28, 2011, which issued during the prosecution of Applicant's PCT/IB2010/052861.
  • A Written Opinion dated Dec. 23, 2011, which issued during the prosecution of Applicant's PCT/IB2010/052861.
  • An International Search Report dated Dec. 3, 2010, which issued during the prosecution of Applicant's PCT/IL2010/000564.
  • A Written Opinion dated Jan. 14, 2012, which issued during the prosecution of Applicant's PCT/IL2010/000564.
  • An International Search Report dated Nov. 5, 2010, which issued during the prosecution of Applicant's PCT/IL2010/000549.
  • A Written Opinion dated Jan. 9, 2012, which issued during the prosecution of Applicant's PCT/IL2010/000549.
  • An International Search Report dated Oct. 6, 2011, which issued during the prosecution of Applicant's PCT/IL2010/000999.
  • An International Search Report dated Mar. 10, 2011, which issued during the prosecution of Applicant's PCT/IL2010/000917.
  • An International Search Report dated Jun. 9, 2011, which issued during the prosecution of Applicant's PCT/IL2010/001018.
  • An International Search Report dated Jun. 16, 2011, which issued during the prosecution of Applicant's PCT/IL2010/001037.
  • An International Search Report dated Jul. 7, 2011, which issued during the prosecution of Applicant's PCT/IL2010/001087.
  • An International Search Report dated Aug. 11, 2011, which issued during the prosecution of Applicant's PCT/IL2011/000135.
  • An International Search Report dated Mar. 11, 2010, which issued during the prosecution of Applicant's PCT/IL2008/001621.
  • A Written Opinion dated Jun. 15, 2010, which issued during the prosecution of Applicant's PCT/IL2008/001621.
  • An International Search Report dated Sep. 3, 2009, which issued during the prosecution of Applicant's PCT/IL2007/001312.
  • A Written Opinion dated Jul. 31, 2009, which issued during the prosecution of Applicant's PCT/IL2007/001312.
  • An English translation of an Office Action dated Aug. 25, 2011, which issued during the prosecution of Chinese Patent Application No. 200880014919.9.
  • An Office Action dated Nov. 12, 2010, which issued during the prosecution of U.S. Appl. No. 12/447,684.
  • An Office Action dated Apr. 27, 2011, which issued during the prosecution of U.S. Appl. No. 12/447,684.
  • “E-vita® open plus” product brochure (JOTEC GmbH, Hechingen, Germany), 2010.
  • Fonseca A et al., “Intravascular ultrasound assessment of the novel AngioSculpt scoring balloon catheter for the treatment of complex coronary lesions,” J Invasive Cardiol 20(1):21-7 (Jan. 2008).
  • Khlif H et al., “Contribution to the Improvement of Textile Vascular Prostheses Crimping,” Trends in Applied Sciences Research 6(9):1019-1027 (2011).
  • International Search Report dated Sep. 29, 2008 in corresponding International Application No. PCT/IL2008/000287.
  • Written Opinion dated Sep. 29, 2008 in corresponding International Application No. PCT/IL2008/000287.
  • International Preliminary Report on Patentability dated Jan. 12, 2010 in corresponding International Application No. PCT/IL2008/000287.
  • First Office Action dated Aug. 25, 2011 issued in Chinese Application No. 200880014919.9.
  • Fonseca et al., Intravascular ultrasound assessment of the novel AngioScuipt scoring balloon catheter for the treatment of complex coronary lesions, J Invasive Cardiol, Jan. 2008, pp. 21-27, vol. 20, No. 1.
  • An Office Action dated Feb. 25, 2013, which issued during the prosecution of U.S. Appl. No. 13/031,871.
  • An Office Action dated Feb. 27, 2013, which issued during the prosecution of U.S. Appl. No. 12/808,037.
  • An Extended European Search Report dated Dec. 13, 2012, which issued during the prosecution of Applicant's European App No. 08719912.1.
  • An International Search Report and a Written Opinion both dated Jun. 14, 2013, which issued during the prosecution of Applicant's PCT/IL2012/050506.
Patent History
Patent number: 8709068
Type: Grant
Filed: Oct 29, 2012
Date of Patent: Apr 29, 2014
Patent Publication Number: 20130090722
Assignee: Endospan Ltd. (Netanya)
Inventors: Alon Shalev (Ra′anana), Rafi Benary (Tel Aviv)
Primary Examiner: Jason-Dennis Stewart
Application Number: 13/663,117
Classifications
Current U.S. Class: Bifurcated (623/1.35); Stent In Combination With Graft (623/1.13); Stent Structure (623/1.15); Means For Inserting Or Removing Conduit Within Body (606/108)
International Classification: A61F 2/06 (20130101); A61F 2/82 (20130101);